SRRK - Scholar Rock Holding Corp - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - SRRK (1727196)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
24 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2024-02-16
SRRKMyles Edward HCOO, CFOS - Sale$15.74-4,744210,976-2%-$74,686
2024-02-16
SRRKQatanani MoCHIEF SCIENTIFIC OFFICERS - Sale$15.74-2,512147,019-2%-$39,547
2024-02-16
SRRKParlavecchio CarynCHROS - Sale$15.74-3,751157,744-2%-$59,053
2024-02-16
SRRKHo JunlinGCS - Sale$15.74-3,489208,771-2%-$54,928
2024-02-16
SRRKBackstrom Jay T.CEOS - Sale$15.74-11,614352,671-3%-$182,842
2024-01-16
SRRKQatanani MoSVP, HEAD OF RESEARCHS - Sale$15.93-2,00278,816-2%-$31,889
2024-01-16
SRRKParlavecchio CarynCHROS - Sale$15.93-2,849114,350-2%-$45,381
2024-01-16
SRRKMyles Edward HCOO, CFOS - Sale$15.93-6,634162,150-4%-$105,670
2024-01-16
SRRKHo JunlinGCS - Sale$15.93-4,186154,405-3%-$66,677
D
2023-12-29
SRRKMyles Edward HCOO, CFOS - Sale+OE$18.83-12,459168,784-7%-$234,633
D
2023-12-14
SRRKQatanani MoSVP, HEAD OF RESEARCHS - Sale+OE$18.18-24,66280,818-23%-$448,444
D
2023-12-07
SRRKMyles Edward HCOO, CFOS - Sale+OE$17.53-24,914168,784-13%-$436,820
2023-11-02
SRRKMyles Edward HCOO, CFOS - Sale$12.51-35,007168,784-17%-$438,039
2023-10-16
SRRKAkkaraju SrinivasDir, 10%P - Purchase$6.85+2,189,7816,788,609+48%+$15,000,000
2023-10-16
SRRKSamsara Biocapital Gp, LLC10%P - Purchase$6.85+2,189,7816,788,609+48%+$15,000,000
2023-10-12
SRRKInvus Public Equities, L.P.10%P - Purchase$6.86+2,199,93111,259,438+24%+$15,086,736
2023-09-18
SRRKQatanani MoSVP, HEAD OF RESEARCHS - Sale$6.34-1,94597,043-2%-$12,331
2023-08-16
SRRKParlavecchio CarynCHROS - Sale$6.83-1,353117,199-1%-$9,241
2023-04-28
SRRKInvus Public Equities, L.P.10%P - Purchase$6.43+31,5579,059,5070%+$202,845
2023-01-09
SRRKInvus Public Equities, L.P.10%S - Sale$9.48-1,0949,027,9500%-$10,373
2023-01-05
SRRKInvus Public Equities, L.P.10%P - Purchase$9.33+48,7749,029,044+1%+$455,091
2022-10-25
SRRKInvus Public Equities, L.P.10%P - Purchase$8.04+130,2658,980,270+1%+$1,047,383
M
2022-10-03
SRRKInvus Public Equities, L.P.10%P - Purchase$7.60+99,9718,850,005+1%+$759,549
D
2022-06-22
SRRKNashat AmirDirP - Purchase$4.90+1,197,992214,338-122%+$5,870,161

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top